Will taking neratinib/neratinib cause an increase in serum creatinine?
Neratinib/Neratinib (Neratinib) is an epidermal growth factor receptor tyrosine kinase inhibitor mainly used to treat certain types of breast cancer. It delays the growth and spread of tumors by inhibiting signaling pathways within tumor cells. However, any drug may have side effects and adverse reactions, and neratinib is no exception.
Serum creatinine is a product of muscle metabolism in the human body and is mainly excreted through glomerular filtration. Elevated blood creatinine usually means that kidney function may be compromised, preventing creatinine from being excreted normally. Neratinib is mainly metabolized by the liver, with most of it excreted in the feces and a small amount excreted in the urine. Therefore, its direct toxic effects on the kidneys are relatively small. However, neratinib's side effects do include effects on the liver and digestive system, which may indirectly affect kidney function. For example, impaired liver function may cause drugs to be metabolized more slowly in the body, increasing the burden on the kidneys to excrete the drug.
In addition, gastrointestinal symptoms caused by neratinib, such as nausea, vomiting, diarrhea, etc., may also lead to dehydration, thereby affecting kidney function. Although neratinib itself does not directly act on the kidneys, it is still necessary to monitor renal function indicators, including serum creatinine, during administration. Especially for those patients who already have kidney disease or poor kidney function, changes in kidney function should be closely monitored.
In general, neratinib may indirectly affect kidney function, leading to an increase in serum creatinine. However, this does not mean that every patient taking neratinib will experience an increase in serum creatinine. According to the clinical trial data and the side effect information in the drug instructions, factors such as the patient's individual situation, medication dosage, and medication time also need to be considered.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)